MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-36-0023522
Dazroz Pharmaceuticals Private Limited
Dazroz Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹54.73 Lakh
▲ 54% YoY
Net profit · FY 2024
₹88,120
Net margin 1.6%
EBITDA · FY 2024
₹88,120
EBITDA margin 1.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Dazroz Pharmaceuticals Private Limited
Data last updated:
Dazroz Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2016PTC274730. Its GSTIN is 27AAFCD7432F1ZQ (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gurvinderpal Kaur and Pritpalsingh Harjindersingh Sundhuria.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No. 162 – Ac L.B.S Marg Nr. Satyajivan Society Kurla, Mumbai, Maharashtra, India – 400070.
As per the financials filed for FY 2024, the company reported a revenue of ₹54.73 Lakh, a growth of 54% compared to the previous year. For the same year it recorded a net profit of ₹88,120 (net margin 1.6%) and EBITDA of ₹88,120 (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 49% over three years.
Dazroz Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-36-0023522). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24230MH2016PTC274730
Registration Number 274730
Incorporation Date 21 March 2016
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-36-0023522
Recognitions & Rankings of Dazroz Pharmaceuticals
Contact details
Dazroz Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressHouse No. 162 – Ac L.B.S Marg Nr. Satyajivan Society Kurla, Mumbai, Maharashtra, India – 400070
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Dazroz Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Dazroz Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Dazroz Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Dazroz Pharmaceuticals Private Limited, buy the company report.
Financials of Dazroz Pharmaceuticals Private Limited
FY 2025 filings availableDazroz Pharmaceuticals Private Limited reported revenue of ₹54.73 Lakh (up 54% YoY) for FY 2024.
Revenue · FY 2024
₹54.73 Lakh ▲ 54%
Net profit · FY 2024
₹88,120 margin 1.6%
EBITDA · FY 2024
₹88,120 margin 1.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 54%
3 years · compounded
▲ 49%
EBITDA CAGR growth
1 year
▲ 57%
3 years · compounded
▲ 178%
Revenue has grown at a compounded annual rate (CAGR) of 49% over three years, including 54% growth in the latest year. EBITDA rose 57% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹88,120 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹88,120 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.6% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dazroz Pharmaceuticals Private Limited, buy the company report.
Board of directors of Dazroz Pharmaceuticals Private Limited
Dazroz Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gurvinderpal Kaur | Director | 21 Mar 2016 | 10 Years 7 Months | Current |
| Pritpalsingh Harjindersingh Sundhuria | Director | 21 Mar 2016 | 10 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Dazroz Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dazroz Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dazroz Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCD7432F1ZQ | Maharashtra | Active | 12 Dec 2017 |
To see the full GST registrations and return filing status of Dazroz Pharmaceuticals Private Limited, buy the company report.
Recent activity
Dazroz Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Gurvinderpal Kaur was appointed as Director on 21 Mar 2016.
AGM
Dazroz Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Dazroz Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Gurvinderpal Kaur was appointed as Director.
Appointed
Pritpalsingh Harjindersingh Sundhuria was appointed as Director.
Incorporation
21 Mar 2016
Dazroz Pharmaceuticals Private Limited was registered on 21 Mar 2016 with Roc Mumbai I & aged 10 years 7 months as per MCA records.
Frequently asked questions
Dazroz Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 March 2016 (10+ years old) and is registered under CIN U24230MH2016PTC274730.
Dazroz Pharmaceuticals has 2 current directors:
- Gurvinderpal Kaur - Director
- Pritpalsingh Harjindersingh Sundhuria - Director
The latest financial statements of Dazroz Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Dazroz Pharmaceuticals is 27AAFCD7432F1ZQ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Dazroz Pharmaceuticals is U24230MH2016PTC274730. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dazroz Pharmaceuticals was incorporated on 21 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Gurvinderpal Kaur was appointed as Director on 21 Mar 2016. Pritpalsingh Harjindersingh Sundhuria was appointed as Director on 21 Mar 2016.
Yes, Dazroz Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-36-0023522).
The registered office of Dazroz Pharmaceuticals is at House No. 162 – Ac L.B.S Marg Nr. Satyajivan Society Kurla, Mumbai, Maharashtra, India – 400070.
Dazroz Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.